Emerging drugs for the treatment of cutaneous T-cell lymphoma.

Cheng, Melissa; Zain, Jasmine; Rosen, Steven T; Querfeld, Christiane

Cheng, Melissa; Zain, Jasmine; Rosen, Steven T; Querfeld, Christiane.

Cheng M; Division of Dermatology, City of Hope National Medical Center, Duarte, CA, USA.
Zain J; Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Pomona, CA, USA.
Rosen ST; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA.
Querfeld C; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA.

Expert Opin Emerg Drugs ; 27(1): 45-54, 2022 03.

Article en En | MEDLINE | ID: mdl-35235473

Asunto(s)

Linfoma Cutáneo de Células T; Neoplasias Cutáneas; Humanos; Inmunoterapia/métodos; Linfoma Cutáneo de Células T/tratamiento farmacológico; Linfoma Cutáneo de Células T/patología; Neoplasias Cutáneas/tratamiento farmacológico; Neoplasias Cutáneas/patología

Palabras clave

CTCL; Cutaneous T cell lymphoma; KIR3DL2; PD1/PD-L1 blockade; TTI-621; antagomir-155; anti-CCR4; anti-CD47; brentuximab-vedotin; cobomarsen; durvalumab; miRNA inhibitors; mogamulizumab; pembrolizumab; peptide inhibitors

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Linfoma Cutáneo de Células T Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google